Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC371

Avacopan (og lyfjafræðilega viðurkennd sölt þess)

  • Status:
    Veitt
  • Application date:
    1.4.2022
  • Application published:
    15.5.2022
  • Grant published:
    15.1.2025
  • Max expiry date:
    20.12.2034
  • Medicine name:
    Tavneos
  • Medicine for children:
    No

Timeline

Today
1.4.2022Application
15.5.2022Publication
15.1.2025Registration
20.12.2034Expires

Marketing license

  • IS authorization number:
    EU/1/21/1605/001-002
  • Date:
    14.2.2022
  • Foreign authorization number:
    EU/1/21/1605
  • Date:
    11.1.2022

Owner

  • Name:
    ChemoCentryx, Inc.
  • Address:
    One Amgen Center Drive, Thousand Oaks, California 91320 US

Agent

  • Name:
    Tego IP ehf.
  • Address:
    Pósthólf 8129, 128 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 05.01.2025

Upload documents